These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

361 related items for PubMed ID: 26086883

  • 21. From DCPD to NTCP: the long journey towards identifying a functional hepatitis B virus receptor.
    Li J, Tong S.
    Clin Mol Hepatol; 2015 Sep; 21(3):193-9. PubMed ID: 26523264
    [Abstract] [Full Text] [Related]

  • 22. Down-regulation of cell membrane localized NTCP expression in proliferating hepatocytes prevents hepatitis B virus infection.
    Yan Y, Allweiss L, Yang D, Kang J, Wang J, Qian X, Zhang T, Liu H, Wang L, Liu S, Sui J, Chen X, Dandri M, Zhao J, Lu F.
    Emerg Microbes Infect; 2019 Sep; 8(1):879-894. PubMed ID: 31179847
    [Abstract] [Full Text] [Related]

  • 23. Viral entry of hepatitis B and D viruses and bile salts transportation share common molecular determinants on sodium taurocholate cotransporting polypeptide.
    Yan H, Peng B, Liu Y, Xu G, He W, Ren B, Jing Z, Sui J, Li W.
    J Virol; 2014 Mar; 88(6):3273-84. PubMed ID: 24390325
    [Abstract] [Full Text] [Related]

  • 24. Robust Human and Murine Hepatocyte Culture Models of Hepatitis B Virus Infection and Replication.
    Qiao L, Sui J, Luo G.
    J Virol; 2018 Dec 01; 92(23):. PubMed ID: 30232184
    [Abstract] [Full Text] [Related]

  • 25. Inhibitors of hepatitis B virus attachment and entry.
    Lempp FA, Urban S.
    Intervirology; 2014 Dec 01; 57(3-4):151-7. PubMed ID: 25034482
    [Abstract] [Full Text] [Related]

  • 26. Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes.
    Ni Y, Lempp FA, Mehrle S, Nkongolo S, Kaufman C, Fälth M, Stindt J, Königer C, Nassal M, Kubitz R, Sültmann H, Urban S.
    Gastroenterology; 2014 Apr 01; 146(4):1070-83. PubMed ID: 24361467
    [Abstract] [Full Text] [Related]

  • 27. Reduced hepatitis B and D viral entry using clinically applied drugs as novel inhibitors of the bile acid transporter NTCP.
    Donkers JM, Zehnder B, van Westen GJP, Kwakkenbos MJ, IJzerman AP, Oude Elferink RPJ, Beuers U, Urban S, van de Graaf SFJ.
    Sci Rep; 2017 Nov 10; 7(1):15307. PubMed ID: 29127322
    [Abstract] [Full Text] [Related]

  • 28. Dual Agonist of Farnesoid X Receptor and Takeda G Protein-Coupled Receptor 5 Inhibits Hepatitis B Virus Infection In Vitro and In Vivo.
    Ito K, Okumura A, Takeuchi JS, Watashi K, Inoue R, Yamauchi T, Sakamoto K, Yamashita Y, Iguchi Y, Une M, Wakita T, Umezawa K, Yoneda M.
    Hepatology; 2021 Jul 10; 74(1):83-98. PubMed ID: 33434356
    [Abstract] [Full Text] [Related]

  • 29. Chemical array system, a platform to identify novel hepatitis B virus entry inhibitors targeting sodium taurocholate cotransporting polypeptide.
    Kaneko M, Futamura Y, Tsukuda S, Kondoh Y, Sekine T, Hirano H, Fukano K, Ohashi H, Saso W, Morishita R, Matsunaga S, Kawai F, Ryo A, Park SY, Suzuki R, Aizaki H, Ohtani N, Sureau C, Wakita T, Osada H, Watashi K.
    Sci Rep; 2018 Feb 09; 8(1):2769. PubMed ID: 29426822
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. NTCP-Reconstituted In Vitro HBV Infection System.
    Sun Y, Qi Y, Peng B, Li W.
    Methods Mol Biol; 2017 Feb 09; 1540():1-14. PubMed ID: 27975303
    [Abstract] [Full Text] [Related]

  • 33. Woodchuck sodium taurocholate cotransporting polypeptide supports low-level hepatitis B and D virus entry.
    Fu L, Hu H, Liu Y, Jing Z, Li W.
    Virology; 2017 May 09; 505():1-11. PubMed ID: 28213271
    [Abstract] [Full Text] [Related]

  • 34. Spinoculation Enhances HBV Infection in NTCP-Reconstituted Hepatocytes.
    Yan R, Zhang Y, Cai D, Liu Y, Cuconati A, Guo H.
    PLoS One; 2015 May 09; 10(6):e0129889. PubMed ID: 26070202
    [Abstract] [Full Text] [Related]

  • 35. A new hepatoma cell line exhibiting high susceptibility to hepatitis B virus infection.
    Ueda Y, Gu W, Dansako H, Nishitsuji H, Satoh S, Shimotohno K, Kato N.
    Biochem Biophys Res Commun; 2019 Jul 12; 515(1):156-162. PubMed ID: 31133379
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Selective hepatitis B and D virus entry inhibitors from the group of pentacyclic lupane-type betulin-derived triterpenoids.
    Kirstgen M, Lowjaga KAAT, Müller SF, Goldmann N, Lehmann F, Alakurtti S, Yli-Kauhaluoma J, Glebe D, Geyer J.
    Sci Rep; 2020 Dec 10; 10(1):21772. PubMed ID: 33303817
    [Abstract] [Full Text] [Related]

  • 39. Synthesis and evaluation of pentacyclic triterpenoids conjugates as novel HBV entry inhibitors targeting NTCP receptor.
    Chen Y, Duan M, Wang X, Xu J, Tian S, Xu X, Duan A, Mahal A, Zhu Y, Zhu Q.
    Bioorg Chem; 2024 Jun 10; 147():107385. PubMed ID: 38663255
    [Abstract] [Full Text] [Related]

  • 40. N-Linked Glycosylation Is Not Essential for Sodium Taurocholate Cotransporting Polypeptide To Mediate Hepatitis B Virus Infection In Vitro.
    Lee J, Zong L, Krotow A, Qin Y, Jia L, Zhang J, Tong S, Li J.
    J Virol; 2018 Aug 01; 92(15):. PubMed ID: 29793953
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.